Janus Kinase Inhibitors - Competitive Landscape, Technology and Pipeline Analysis, 2016; New Report Launched
Janus Kinase (JAK) Inhibitors - Competitive Landscape, Technology and Pipeline Analysis, 2016 report provides comprehensive insights about pipeline drugs across this Mechanism of action. Key objective of the report is to establish the understanding for all the pipeline drugs that fall under Janus Kinase (JAK) Inhibitors.
View full press release